


Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. An audio archive of all the presentations will also be available on the website. Webcasts of all events will be available in the Investor Relations section of the Company’s website. Launched ProFound AI Risk Offering After Receiving CE Mark in Europe Recent 50 System Agreement with SimonMed Imaging Highlights Significant Value of ProFound AI SolutionExpert Panel Reviews Compelling Clinical Data on Xoft® Brain IORTConference Call Today at 4:30 p.m. 18th Annual Craig-Hallum Institutional Investor Conference will host virtual 1x1 meetings on June 2, 2021.The 2021 Jefferies Virtual Healthcare Conference on Tuesday, Jwill host a live presentation starting at 3:00 p.m.Oppenheimer’s MedTech, Tools & Diagnostics Summit will post a pre-recorded presentation on Wednesday, May 26, 2021.(NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, iCAD’s Chairman and Chief Executive Officer, will be participating at the following three virtual investor conferences in May and June: NASHUA, N.H., (GLOBE NEWSWIRE) - iCAD, Inc. iCAD inc (Symbol: ICAD) options are showing a volume of 1,218 contracts thus far today.
